Wikidata

(Q61981436)

English

Panitumumab and Pegylated Liposomal Doxorubicin for Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-type

clinical trial

In more languages

Statements

short name
PaLiDo (English)
0 references
title
Panitumumab and Pegylated Liposomal Doxorubicin for Platinum-Resistant Epithelial Ovarian Cancer With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Wild-type (English)
0 references
country
Austria
0 references
Belgium
0 references
Denmark
0 references
Sweden
0 references
start time
April 2009
0 references
end time
August 2011
0 references
number of participants
33
0 references
research intervention
doxorubicin
0 references
Caelyx
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61981436&oldid=2149152871"